Fujitsu is utilizing generative AI to accelerate drug development. There are concerns among experts about the exaggerated claims surrounding generative AI's impact on healthcare, with comparisons to past disappointments like IBM's Dr. Watson. Nvidia also asserts that generative AI will transform healthcare.
Will generative AI in health care result in another letdown? https://t.co/vehrYU95Zs
Many experts fear that the overheated rhetoric around the use of AI in medicine, and the thinly veiled profit motives behind it, could lead to yet another letdown -- just like what happened with IBM's Dr. Watson, @caseymross reports: https://t.co/QUIClJTORF via @statnews
Tap. The. Brakes. Nvidia $NVDA says generative AI will revolutionize health care. So did IBM, with Dr. Watson https://t.co/syfDD7Fse3 via @caseymross
Nvidia says generative AI will revolutionize health care. So did IBM, with Dr. Watson https://t.co/8GCgRdfsOj
From the rhetoric, you'd think generative AI had cured cancer or Alzheimer's. It hasn't. It's showed, in proof of concept, that it might save health care businesses some time and money. Does that make it revolutionary? via @statnews: https://t.co/P4DpWVmMvp via @statnews
Many doctors and computer scientists fear that the breathless rhetoric about generative AI's powers could lead to yet another letdown. https://t.co/a9Q2V1D05H
Fujitsu taps generative AI to help speed drug development https://t.co/jc5tEwPh3E